Why a SCOTUS Ruling on Fishing Rules Could Change How FDA Regulates Drugs
Posted
Frank Vinluan (via MedCity News)
Three upcoming Supreme Court decisions have the potential to radically change FDA regulation of medications.
The cases, which involve “Chevron deference” and the abortion pill mifepristone, were discussed on a panel during the BIO conference in San Diego.
The post Why a SCOTUS Ruling on Fishing Rules Could Change How FDA Regulates Drugs appeared first on MedCity News.
